Form 4 for AMPX Amprius Technologies, Inc.
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-10 · accession 0001899287-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-12 | 2025-03-10 | AMPX | Bornstein Jonathan | Pres of Amprius Lab | M - OptEx | $0.98 | +3,471 | 422.7K | +0.8% | +$3,402 |
| D | 2025-03-12 | 2025-03-10 | AMPX | Bornstein Jonathan | Pres of Amprius Lab | M - OptEx | $0.00 | -3,471 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-03-10 | M | A | 3,471 | $0.98 | 422,668 | D | — | — | (F1) Includes 419,197 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit. |
| 2 | Derivative | Stock Option (right to buy) | 2025-03-10 | M | D | 3,471 | $0.00 | 0 | D | $0.98 · 2016-01-01 to 2025-03-17 | 3,471 Common stock |